Prediction of Bone Metastasis in Prostate Cancer Using Blood Glucose-6-Phosphate Dehydrogenase Activity: A Retrospective Medical Record Review

Chang-Hwan Yeom, Jiewon Lee, Keun-Joo Bae, Kangseok Kim, Jongsoon Choi, Myeong-Hun Lim · 2025

Read Prediction of Bone Metastasis in Prostate Cancer Using Blood Glucose-6-Phosphate Dehydrogenase Activity: A Retrospective Medical Record Review by Chang-Hwan Yeom, Jiewon Lee, Keun-Joo Bae, Kangseok Kim, Jongsoon Choi, Myeong-Hun Lim (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12784825.txt.

Description

Chang-Hwan Yeom and five co-authors test a blood enzyme as a warning sign for prostate cancer spread in a 2025 record review. Bone is the most common site this cancer spreads to, and knowing the risk early shapes treatment choices. The enzyme, called G6PD, helps cells handle energy and stress.

The team compared enzyme activity in 56 patients with and without bone spread. Activity ran much higher in those whose cancer had reached bone. A standard accuracy test rated the marker fairly good, and the authors set a cutoff value that caught most cases while clearing most others. They present the enzyme level as a simple, non-invasive extra tool for judging spread risk.

Catalog record

CREATORChang-Hwan Yeom, Jiewon Lee, Keun-Joo Bae, Kangseok Kim, Jongsoon Choi, Myeong-Hun Lim
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE21 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12784825

Browse the full library · About the Tower of Babel